News and blogs
56 results found.
What's the latest evidence regarding COVID-19 vaccines and blood cancer?
Lots of information continues to circulate about COVID-19 and vaccinations for immunocompromised people. Blood Cancer UK’s Healthcare Professional Advisory Panel (HPAP), made up of specialists from across the UK working in haemato-oncology and related professional fields, has released the statement below to help you understand the latest evidence.
How our research gave vaccine answers to people with blood cancer
As our QResearch project formally comes to a close, we look at how scientists were able to understand the effectiveness of the COVID-19 vaccine for clinically extremely vulnerable people during the pandemic.
We're calling for UK wide guidance for healthcare staff on masks and testing
As we head into winter, and COVID rates rising, we want to help protect those with blood cancer. We’re calling for UK-wide guidance to be reintroduced asking healthcare staff, to wear masks in clinical settings.
Paxlovid rebound: what we know
Paxlovid is the most commonly prescribed treatment for people with severe immunosuppression who test positive for covid-19. We look at the phenomenon called Paxlovid rebound and what it might mean for the future of Paxlovid treatment.
Evusheld available in the UK to buy privately
Evusheld is available privately in the UK. Here’s what we know about how to access it.
Blood cancer and covid: making choices that work for you
We know it's still an uncertain time for the blood cancer community, with many people trying to find the right balance between protecting themselves from the virus and looking after their mental well-being.
Evusheld – is it effective?
In this blog, we talk about what the latest research is telling us about how effective Evusheld is.
Evusheld Covid antibody treatment - what you need to know
Find out more about the Covid antibody treatment Evusheld (formely AZD7442), which consists of two long-acting antibodies called tixagevumab and cilgavimab.
Our response to Evusheld – a treatment to prevent Covid for the immunosuppressed
While we welcome the news of a new Covid treatment for immunosuppressed people – called Evusheld – we call for the Government to urgently set out its approach on how it will use preventative treatments for them.
Why are people with blood cancer invited for a 5th vaccine dose (second booster)?
People with blood cancer are now being offered a second covid vaccine booster (a 5th vaccine dose). Here's why.
I've got leukaemia and caught Covid two weeks ago
Stephen Pollard, Editor at large for the Jewish Chronicle, lives with chronic lymphocytic leukaemia and has spent the last couple of years trying to avoid Covid. But two weeks ago, he tested positive. We asked him to write about his experience.
How our blood cancer and Covid survey has led to change
We’re writing this to update you on what our recent survey on blood cancer and Covid found, what has happened since, and the impact it made.
“Alarming” racial inequality in third vaccine doses for the immunocompromised
New data has shown that take-up of the third vaccine dose among white British people is almost double that of some ethnic minorities. Here's our response.
Latest Updates from the Vaccine Research Collaborative
Welcome to our live blog all about research looking at the effectiveness of the covid vaccines in people with blood cancer.
Blood Cancer UK’s approach to in-person events
Our Chief Executive, Gemma Peters, explains our decision to hold in-person events again.
Omicron variant and people with blood cancer
What can people with blood cancer and those around them do about the risk of Omicron?
Why am I being invited for another Covid vaccine? - Third doses and boosters
Anyone who is immunocompromised, including anyone with blood cancer, is now eligible for a booster (fourth dose) of the Covid vaccine, to be given three months after their third primary dose. In this blog, we explain more.
Antivirals and monoclonal antibodies – what’s the difference?
We’ve been hearing about new treatments that the UK have bought to tackle Covid. Some drugs have already been approved for use in the UK, some are yet to be – but the hope is that they will help those most at risk of severe Covid.
What should you do if you have blood cancer and cannot get a third Covid vaccine dose?
With many people reporting issues with the rollout of third doses of the vaccine, we’ve set out what you can do right now to try to get your third dose if you have not already been invited for it.
How we helped Covid booster vaccine research
Discover how Blood Cancer UK played a key part in Covid booster vaccine research for immune compromised patients, helping to create the OCTAVE-DUO study.
